Inspiremd Share Price Today
(NASDAQ: NSPR)

Name: Inspiremd Share Price Today (NASDAQ: NSPR) - Inspiremd Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Inspiremd share price is $2.9 & ₹252.21 as on 6 Mar 2025, 2.30 'hrs' IST

$2.9

▲

-0.08

(-2.68%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Inspiremd share price in Dollar and Rupees. Guide to invest in Inspiremd stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Inspiremd, along with analyst recommendations, forecasts, and comprehensive financials.

Inspiremd share price movements

Today's Low: $2.86
Today's High: $3.10
$2.90
1.38%
Downside
Day's Volatility :7.74%
Upside
6.45%
52 Weeks Low: $1.81
52 Weeks High: $3.80
$2.90
37.59%
Downside
52 Weeks Volatility :52.34%
Upside
23.64%

Inspiremd (NSPR) Returns

Period	Inspiremd Inc	Index (Russel 2000)
3 Months	-3.65%	0.0%
6 Months	5.84%	0.0%
1 Year	14.62%	0.0%
3 Years	10.27%	-11.6%

Inspiremd (NSPR) Key Statistics

in dollars & INR

Previous Close	$2.98
Open	$2.98
Today's High	$3.1
Today's Low	$2.86
Market Capitalization	$75.6M
Today's Volume	$88.4K
52 Week High	$3.798
52 Week Low	$1.81
Revenue TTM	$6.8M
EBITDA	$-29.7M
Earnings Per Share (EPS)	$-0.71
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-66.75%

How to invest in Inspiremd Stock (NSPR) from India?

It is very easy for Indian residents to invest directly in Inspiremd from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inspiremd stock in both Indian Rupees (INR) and US Dollars (USD). Search for Inspiremd or NSPR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inspiremd or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Inspiremd shares which would translate to 0.300 fractional shares of Inspiremd as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Inspiremd, in just a few clicks!

Returns in Inspiremd (NSPR) for Indian investors in Rupees

The Inspiremd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Inspiremd investment value today

Current value as on today

₹1,19,573

Returns

₹19,573

(+19.57%)

Returns from Inspiremd Stock

₹14,625 (+14.62%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Inspiremd (NSPR)

-50%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Inspiremd Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Inspiremd

Rosalind Advisors, Inc.
9.57%
Orbimed Advisors, LLC
8.18%
Marshall Wace Asset Management Ltd
7.13%
Nantahala Capital Management, LLC
6.42%
Soleus Capital Management, L.P.
5.28%
Velan Capital Investment Management LP
3.47%

Analyst Recommendation on Inspiremd

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Inspiremd(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Inspiremd Stock (NSPR)

What analysts predicted

Upside of 63.79%

Target:

$4.75

Current:

$2.90

Insights on Inspiremd Stock (Ticker Symbol: NSPR)

Price Movement
In the last 7 days, NSPR stock has moved down by -13.7%
Increasing Revenue
Revenue is up for the last 3 quarters, 1.51M → 1.81M (in $), with an average increase of 8.5% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -7.90M → -7.89M (in $), with an average increase of 0.2% per quarter
NSPR vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 40.7%
NSPR vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 127.5%
Price to Sales
ForNSPR every $1 of sales, investors are willing to pay $16.1, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

NSPR Inspiremd Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$3.6M	↑ 30.42%
Net Income	$-7.2M	↓ 14.2%
Net Profit Margin	-201.06%	↑ 104.55%

	FY19	Y/Y Change
Revenue	$3.7M	↑ 3.33%
Net Income	$-10.0M	↑ 38.67%
Net Profit Margin	-269.82%	↓ 68.76%

	FY20	Y/Y Change
Revenue	$2.5M	↓ 33.22%
Net Income	$-10.5M	↑ 5.02%
Net Profit Margin	-424.31%	↓ 154.49%

	FY21	Y/Y Change
Revenue	$4.5M	↑ 80.89%
Net Income	$-14.9M	↑ 41.48%
Net Profit Margin	-331.88%	↑ 92.43%

	FY22	Y/Y Change
Revenue	$5.2M	↑ 15.04%
Net Income	$-18.5M	↑ 23.95%
Net Profit Margin	-357.59%	↓ 25.71%

	FY23	Y/Y Change
Revenue	$6.2M	↑ 20.0%
Net Income	$-19.9M	↑ 7.71%
Net Profit Margin	-320.97%	↑ 36.62%

	Q2 FY23	Q/Q Change
Revenue	$1.6M	↑ 33.09%
Net Income	$-5.1M	↑ 22.9%
Net Profit Margin	-307.88%	↑ 25.53%

	Q3 FY23	Q/Q Change
Revenue	$1.6M	↓ 5.64%
Net Income	$-5.2M	↑ 1.99%
Net Profit Margin	-332.78%	↓ 24.9%

	Q4 FY23	Q/Q Change
Revenue	$1.8M	↑ 13.17%
Net Income	$-5.4M	↑ 4.38%
Net Profit Margin	-306.93%	↑ 25.85%

	Q1 FY24	Q/Q Change
Revenue	$1.5M	↓ 14.2%
Net Income	$-7.0M	↑ 30.1%
Net Profit Margin	-465.39%	↓ 158.46%

	Q2 FY24	Q/Q Change
Revenue	$1.7M	↑ 15.09%
Net Income	$-7.9M	↑ 12.47%
Net Profit Margin	-454.8%	↑ 10.59%

	Q3 FY24	Q/Q Change
Revenue	$1.8M	↑ 4.08%
Net Income	$-7.9M	↓ 0.24%
Net Profit Margin	-435.91%	↑ 18.89%

	FY18	Y/Y Change
Profit	$995.0K	↑ 70.09%

	FY19	Y/Y Change
Profit	$756.0K	↓ 24.02%

	FY20	Y/Y Change
Profit	$83.0K	↓ 89.02%

	FY21	Y/Y Change
Profit	$754.0K	↑ 808.43%

	FY22	Y/Y Change
Profit	$1.1M	↑ 48.14%

	FY23	Y/Y Change
Profit	$1.8M	↑ 61.77%

	Q2 FY23	Q/Q Change
Profit	$491.0K	↑ 31.64%

	Q3 FY23	Q/Q Change
Profit	$438.0K	↓ 10.79%

	Q4 FY23	Q/Q Change
Profit	$505.0K	↑ 15.3%

	Q1 FY24	Q/Q Change
Profit	$292.0K	↓ 42.18%

	Q2 FY24	Q/Q Change
Profit	$331.0K	↑ 13.36%

	Q3 FY24	Q/Q Change
Profit	$414.0K	↑ 25.08%

	FY18	Y/Y Change
Operating Cash Flow	$-7.6M	↓ 6.46%
Investing Cash Flow	$-44.0K	↓ 86.16%
Financing Cash Flow	$13.4M	↑ 188.58%

	FY19	Y/Y Change
Operating Cash Flow	$-9.8M	↑ 28.98%
Investing Cash Flow	$-387.0K	↑ 779.55%
Financing Cash Flow	$6.3M	↓ 52.62%

	FY20	Y/Y Change
Operating Cash Flow	$-9.1M	↓ 7.43%
Investing Cash Flow	$-187.0K	↓ 51.68%
Financing Cash Flow	$16.4M	↑ 158.8%

	FY21	Y/Y Change
Operating Cash Flow	$-13.2M	↑ 45.47%
Investing Cash Flow	$-22.5M	↑ 11909.09%
Financing Cash Flow	$35.0M	↑ 113.69%

	FY22	Y/Y Change
Operating Cash Flow	$-15.5M	↑ 17.65%
Investing Cash Flow	$8.4M	↓ 137.59%
Financing Cash Flow	$-140.0K	↓ 100.4%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-3.3M	↓ 31.17%
Investing Cash Flow	$-26.9M	↓ 704.43%
Financing Cash Flow	$37.5M	↑ 0.0%

Inspiremd Technicals Summary

Sell

Neutral

Buy

Inspiremd is currently in a neutral trading position according to technical analysis indicators.

Inspiremd (NSPR) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inspiremd Inc	10.27%	5.84%	14.62%	10.27%	-76.42%
Medtronic Plc	3.4%	5.22%	9.95%	-11.8%	1.8%
Edwards Lifesciences Corp.	2.13%	10.35%	-17.53%	-32.76%	14.39%
Boston Scientific Corp.	1.13%	28.68%	55.31%	146.09%	207.16%
Stryker Corporation	0.84%	10.53%	11.46%	56.15%	129.21%
Abbott Laboratories	6.67%	21.76%	15.39%	15.86%	78.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inspiremd Inc	NA	NA	0.0	-0.78	-0.67	-0.37	NA	1.61
Medtronic Plc	28.71	28.71	1.91	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	31.13	31.13	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	84.24	84.24	1.87	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.77	50.77	2.91	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inspiremd Inc	Buy	$75.6M	-76.42%	NA	0.0%
Medtronic Plc	Buy	$119.3B	1.8%	28.71	12.83%
Edwards Lifesciences Corp.	Buy	$42.8B	14.39%	31.13	76.75%
Boston Scientific Corp.	Buy	$152.9B	207.16%	84.24	11.07%
Stryker Corporation	Buy	$148.8B	129.21%	50.77	13.25%
Abbott Laboratories	Buy	$238.6B	78.8%	18.34	31.95%

About Inspiremd

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Organization	Inspiremd
Employees	80
CEO	Mr. Marvin L. Slosman
Industry	Health Technology

Management People of Inspiremd

Name	Title
Mr. Marvin L. Slosman	President, CEO & Director
Mr. Craig Shore	CFO, Chief Administrative Officer, Secretary & Treasurer
Mr. Shane Thomas Gleason	Chief Commercial Officer
Mr. Andrea Tommasoli	Chief Operating Officer
Mr. Amir Kohen	Senior Vice President of Finance & HR
Dr. Patrick A. Verta DVM, M.D., MS Stat	Executive Vice President of Clinical & Medical Affairs
Mr. Pete J. Ligotti	Executive VP & GM of North America
Dr. Sol J. Barer Ph.D.	Special Advisor to the Board

Important FAQs about investing in NSPR Stock from India :

What is Inspiremd share price today?

Inspiremd share price today stands at $2.90, Open: $2.98 ; Previous Close: $2.98 ; High: $3.10 ; Low: $2.86 ; 52 Week High: $3.80 ; 52 Week Low: $1.81.

The stock opens at $2.98, after a previous close of $2.98. The stock reached a daily high of $3.10 and a low of $2.86, with a 52-week high of $3.80 and a 52-week low of $1.81.

Can Indians buy Inspiremd shares?

Yes, Indians can invest in the Inspiremd (NSPR) from India.

With INDmoney, you can buy Inspiremd at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Inspiremd at zero transaction cost.

How can I buy Inspiremd shares from India?

It is very easy to buy Inspiremd from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Inspiremd (NSPR) be purchased?

Yes, you can buy fractional shares of Inspiremd with INDmoney app.

What are the documents required to start investing in Inspiremd stocks?

To start investing in Inspiremd, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.